SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,000 | -66.7% | 144 | -7.1% | 0.00% | – |
Q4 2021 | $6,000 | -96.5% | 155 | – | 0.00% | -100.0% |
Q3 2021 | $170,000 | +7.6% | 0 | – | 0.08% | +40.4% |
Q2 2021 | $158,000 | +56.4% | 0 | -100.0% | 0.06% | +2750.0% |
Q1 2021 | $101,000 | +2425.0% | 1 | -96.2% | 0.00% | -99.8% |
Q2 2020 | $4,000 | -99.3% | 26 | +420.0% | 1.23% | +61250.0% |
Q1 2020 | $547,000 | +379.8% | 5 | -72.2% | 0.00% | -97.5% |
Q4 2019 | $114,000 | +5600.0% | 18 | -10.0% | 0.08% | +3850.0% |
Q3 2019 | $2,000 | +100.0% | 20 | 0.0% | 0.00% | +100.0% |
Q2 2019 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,000 | 0.0% | 20 | -4.8% | 0.00% | 0.0% |
Q3 2018 | $1,000 | -50.0% | 21 | -4.5% | 0.00% | -50.0% |
Q2 2018 | $2,000 | +100.0% | 22 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $1,000 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |